There were 1,280 press releases posted in the last 24 hours and 435,398 in the last 365 days.

CFO Jimmy Patronis Statement on Historic COVID-19 Vaccine Arrival in Florida

12/14/2020

CFO Jimmy Patronis Statement on Historic COVID-19 Vaccine Arrival in Florida 

TALLAHASSEE, Fla. – Today, Chief Financial Officer (CFO) Jimmy Patronis released the following statement regarding the distribution of the COVID-19 vaccine to hospitals in Florida.   CFO Jimmy Patronis said, “Today is a historic day for our nation and the great state of Florida as the first wave of the COVID-19 vaccine was delivered to major hospitals in our state. This is a tremendous milestone and a culmination of incredible work by President Donald Trump and Operation Warp Speed, Governor Ron DeSantis, and our heroic healthcare professionals working around the clock to serve our communities throughout this pandemic. This is nothing short of a game changer and no small task to cut through the red tape and accelerate vaccine development while maintaining standards for safety and efficacy.   “Thank you again to Governor Ron DeSantis and the entire team at the Florida Division of Emergency Management for their tireless efforts to protect Floridians and help coordinate the largest mass vaccination effort in U.S. history. This is a huge win for Florida and vital to saving lives and getting our economy back on its feet.”   ###

About CFO Jimmy Patronis Chief Financial Officer and State Fire Marshal Jimmy Patronis is a statewide elected official and a member of Florida’s Cabinet who oversees the Department of Financial Services. CFO Patronis works each day to fight insurance fraud, support Florida’s firefighters, and ensure the state’s finances are stable to support economic growth in the state. Follow the activities of the Department on Facebook (FLDFS) and Twitter (@FLDFS).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.